<DOC>
	<DOCNO>NCT00851383</DOCNO>
	<brief_summary>The purpose study evaluate safety immunogenicity Ad35-GRIN/ENV HIV vaccine Ad35-GRIN HIV vaccine administer intramuscularly 0 6 month .</brief_summary>
	<brief_title>A Trial Evaluate Ad35-GRIN/ENV HIV Vaccine Healthy Adult Volunteers</brief_title>
	<detailed_description>This study phase I dose-escalation randomized , placebo-controlled study design evaluate safety immunogenicity Ad35-GRIN Ad35-ENV fill vial administered single , combined vaccine . This first administration vaccine human . The study double blind respect vaccine placebo . The vaccine administer intramuscularly month 0 6 three dose level : 2 x 10^9 , 2 x 10^10 , 2 x 10^11 vp per dose . Volunteers randomize vaccine : placebo 10:4 ratio group . A fourth group add protocol amendment study Ad35-GRIN HIV vaccine alone 1x10^10 vp 14 volunteer ( 10:4 vaccine : placebo ) . Volunteers screen 42 day vaccination ( 90 day Ad35 neutralize antibody screen ) follow 12 month last vaccination ( 18 month total study participation ) . Estimated enrollment take approximately 5 month . Thus , total duration study would approximately 23 month .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Inclusion Criteria Healthy male female , assess medical history , physical exam , laboratory test Willing comply protocol follow plan duration study ( screen plus 18 month ) In opinion PI designee , understood information provide . Written informed consent need give studyrelated procedure perform Amenable HIV risk reduction counseling , commit maintain behavior consistent low risk HIV exposure last required visit , willing continue 5 yrs annual followup contact Demonstrates understand ( assessment understanding perform ) risk harm observe STEP Study result Assessed clinic staff `` low risk '' HIV infection basis sexual behavior within 12 month prior enrolment define follow : Sexually abstinent OR Had two few mutually monogamous relationship partner believe HIVuninfected use illicit drug ( methamphetamine ( crystal meth ) , heroin , cocaine , include crack cocaine chronic marijuana abuse ) OR Had two few partner believe HIVuninfected use illicit drug ( methamphetamine ( crystal meth ) , heroin , cocaine , include crack cocaine chronic marijuana abuse ) , he/she regularly use condom vaginal anal intercourse Willing undergo HIV Testing , HIV counsel receive HIV Test result If sexually active female , use effective method contraception ( hormonal contraceptive ; diaphragm ; Intra Uterine Device ( IUD ) ; condom ; anatomical sterility self partner ) screen least 4 month last vaccination . All female volunteer must willing undergo urine pregnancy test time point indicate Schedule Procedures If sexually active male , willing use effective method contraception ( condom , anatomical sterility ) screen 4 month last vaccination Exclusion Criteria Confirmed HIV1 HIV2 infection Detection Ad35specific serum neutralize antibody Reported highrisk behavior HIV infection define : Within 12 month vaccination , volunteer : Had unprotected vaginal anal sex know HIV infect person casual partner ( i.e . continue establish relationship ) Engaged sex work money drug . Excessive daily alcohol use frequent binge drinking chronic marijuana use use illicit drug . Recently acquire sexually transmit disease ( STD ) include syphilis , gonorrhoea , nongonococcal urethritis , Trichomonas vaginalis , symptomatic Herpes genitalis ( HSV2 ) , chlamydia , pelvic inflammatory disease ( PID ) , mucopurulent cervicitis , epididymitis , proctitis , lymphogranuloma venereum , chancroid , hepatitis B ) . Has highrisk partner either currently partner within previous 12 month . Any clinically significant abnormality history examination , include history immunodeficiency autoimmune disease ; use systemic corticosteroid ( use topical steroid inhale steroid sinus decongestion permit ) , immunosuppressive , antiviral , anticancer , antituberculosis , medication consider significant investigator within previous 6 month ; Any clinically significant acute chronic medical condition consider progressive , opinion investigator , would make volunteer unsuitable study . Any following abnormal laboratory parameter Hemoglobin &lt; 11.0 g/dL woman &lt; 12.5 g/dL men Absolute Neutrophil Count ( ANL ) : ≤ 999/mm3 Absolute Lymphocyte Count ( ALC ) : ≤ 500/mm3 Platelets : ≤ 90,000 ≥ 550,000/mm3 Creatinine : &gt; 1.1 ULN AST : &gt; 1.25 x ULN ALT : &gt; 1.25 x ULN Urinalysis 2+ urine dipstick Blood ( due menses ) ; Protein Leucocytes Confirmed diagnosis hepatitis B ( surface antigen HbsAg ) , hepatitis C ( HCV antibody ) , active syphilis If female , pregnant planning pregnancy within 4 month last vaccination ; lactate Receipt live attenuate vaccine within previous 60 day ( live attenuate flu vaccine within 14 day ) plan receipt within 60 day vaccination Investigational Product receipt vaccine within previous 14 day plan receipt within 14 day vaccination Investigational Product Receipt blood transfusion blood product within previous 6 month Participation another clinical study investigational product currently , within previous 3 month expect participation study Receipt another investigational HIV vaccine candidate time History severe severe local systemic reactogenicity vaccine history severe allergic reaction Major psychiatric illness , include history schizophrenia severe psychosis , bipolar disorder require therapy , suicidal attempt ideation previous 3 yr Unwilling forgo donation blood , sperm , egg , bone marrow organ study Asplenia : condition result absence spleen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>HIV</keyword>
	<keyword>Human Immunodeficiency Virus</keyword>
	<keyword>HIV Seronegativity</keyword>
	<keyword>Preventive Vaccine</keyword>
</DOC>